Holen Sie sich die Stockscreener-App
1.81
2.26%
0.04
Schlusskurs vom Vortag:
$1.77
Offen:
$1.78
24-Stunden-Volumen:
7,642
Relative Volume:
0.07
Marktkapitalisierung:
$72.28M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-1.0838
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
+6.47%
1M Leistung:
-5.73%
6M Leistung:
-30.38%
1J Leistung:
-38.85%
1-Tages-Spanne:
$1.78
$1.8246
1-Wochen-Bereich:
$1.66
$1.89
52-Wochen-Spanne:
$0.8645
$3.26
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.8246 | 67.35M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
132.07 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.68 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
393.47 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.56 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
82.05 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio Posts Double-Digit Revenue Growth, Expands Product Reach in Q2 - MSN
Leading vs lagging indicators on TELA Bio Inc. performance2025 Trade Ideas & Reliable Intraday Trade Alerts - Newser
How TELA Bio Inc. stock performs during market volatilityQuarterly Portfolio Summary & Technical Entry and Exit Alerts - thegnnews.com
How to use Fibonacci retracement on TELA Bio Inc.2025 EndofYear Setup & Free High Return Stock Watch Alerts - Newser
Is TELA Bio Inc. forming a bottoming baseJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser
Can trapped investors hope for a rebound in TELA Bio Inc.Quarterly Portfolio Review & Reliable Volume Spike Trade Alerts - Newser
Using flow based indicators on TELA Bio Inc.Portfolio Return Report & Growth-Oriented Investment Plans - Newser
Can swing trading help recover from TELA Bio Inc. lossesCPI Data & Stock Portfolio Risk Management - Newser
Resistance Break Could Fuel TELA Bio Inc. RallyQuarterly Portfolio Summary & Weekly Stock Performance Updates - beatles.ru
TELA Bio Inc. stock trend forecastJuly 2025 Earnings & Capital Efficiency Focused Ideas - Newser
TELA Bio Awards Inducement Equity Grants to New Employees - MSN
TELA Bio’s SWOT analysis: biologic innovator’s stock faces growth hurdles - Investing.com India
Investors Give TELA Bio, Inc. (NASDAQ:TELA) Shares A 27% Hiding - 富途牛牛
Insider Traders Lose US$143k As TELA Bio Drops - simplywall.st
Tools to assess TELA Bio Inc.’s risk profileJuly 2025 Update & Verified Momentum Watchlists - Newser
TELA Bio’s SWOT analysis: biologic innovator’s stock faces growth hurdles By Investing.com - Investing.com South Africa
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates - MSN
Tela Bio at Canaccord Conference: Strategic Growth in Soft Tissue Repair - Investing.com Canada
Tela Bio shares fall 2.50% premarket after announcing inducement grants to new employees. - AInvest
Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates - MSN
Will TELA Bio Inc. stock benefit from AI tech trendsSwing Entry Risk Mitigation with Chart Analysis - Newser
Tela Bio shares fall 6.88% after-hours following inducement grants to new employees. - AInvest
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)August 8, 2025 - MarketScreener
TELA Bio (TELA) Gets a Buy from Lake Street - The Globe and Mail
TELA Bio 2025 Q2 Earnings Net Loss Narrows Amid Revenue Growth - AInvest
TELA Bio Reports Strong Q2 2025 Financial Results - MSN
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
TELA Bio Inc (TELA) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
TELA Bio Reports Strong Q2 2025 Growth - TipRanks
TELA Bio Reports Second Quarter 2025 Financial Results - GlobeNewswire
TR | OpenAI4o Maintains TELA Bio(TELA.US) With Hold Rating, Maintains Target Price $2 - 富途牛牛
TELA Bio’s Revenue Climbed But Fell Short Of Expectations - Finimize
Contradictions Unveiled: TELA Bio's Q2 2025 Earnings Call Highlights Shifts in Sales Strategy, Product Growth, and Pricing Positioning - AInvest
Tela Bio (TELA): A Compelling Post-Earnings Case for Long-Term Value Creation in a High-Growth MedTech Sector - AInvest
Tela Bio's 2025 Revenue Guidance and Global Expansion: A Strategic Inflection Point for Scalable Growth - AInvest
Tela Bio Exceeds $20M Revenue in Q2 2025, Reiterates $85M-$88M 2025 Target Amid International Expansion - AInvest
Earnings call transcript: Tela Bio Q2 2025 sees stock rise despite EPS miss - Investing.com Canada
Earnings call transcript: Tela Bio Q2 2025 sees stock rise despite EPS miss By Investing.com - Investing.com South Africa
Tela Bio earnings missed by $0.04, revenue fell short of estimates - Investing.com Canada
Tela Bio reports Q2 EPS (22c), consensus (19c) - TipRanks
Intraday pattern recognizer results for TELA Bio Inc.Daily Stock Watch Summary with Key Insights - Newser
TELA Bio's Q2 Revenue Miss: A Crossroads of Short-Term Pressures and Long-Term R&D Promise in Biotech - AInvest
TELA Bio misses Q2 revenue estimates - MarketScreener
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tela Bio Inc-Aktie (TELA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
0.09%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):